ArticleCentral European journal of urology2026
Impact of preoperative ureteral stenting on perioperative outcomes in percutaneous nephrolithotomy.
Article in Central European journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The impact of preoperative ureteral stenting on perioperative outcomes in percutaneous nephrolithotomy (PCNL) remains unexplored. This study addresses this knowledge gap to guide evidence-based clinical practice. Material and methods: We retrospectively analyzed consecutive PCNL patients treated at LMU University Hospital Munich between December 2012 and April 2025 (n = 374), and compared perioperative outcomes between prestented and non-prestented patients. Patients who underwent endoscopic combined intrarenal surgery (ECIRS, n = 154) or simultaneous bilateral endoscopic surgery (SBES, n = 23) were excluded to avoid confounding from concurrent ureteroscopy. Results: A total of 197 PCNL patients were included (median age 55 years, 64% male). Preoperative ureteral stenting was performed in 78 patients (40%), while 119 patients (60%) underwent PCNL without prestenting. No significant differences were observed between the two groups regarding age, gender, BMI, ASA score, stone radiodensity, or stone composition. Guy's Stone Score did not differ significantly between groups (median 2, IQR 1-3; p = 0.221), although prestented patients had a slightly higher stone count. Operative time (103 vs 97 minutes; p = 0.814) and complication rates (10% vs 11%; p = 0.963) were similar, with fever being the most common complication. Radiation exposure, laboratory parameters, and hospital stay did not differ between groups. On multivariable logistic regression, prestenting (OR = 2.83, 95% CI: 1.09-7.38; p = 0.033), longer operative time, Guy's Stone Score 4, and greater stone number were independent predictors of not achieving stone-free status. Conclusions: Unless urgently indicated, preoperative ureteral stenting before PCNL should be omitted, because it confers additional procedural burden and stent-related morbidity without improving perioperative outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.